New patent for Impel Neuropharma drug TRUDHESA

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for TRUDHESA
Annual Drug Patent Expirations for TRUDHESA

Trudhesa is a drug marketed by Impel Neuropharma and is included in one NDA. There are four patents protecting this drug.

This drug has thirty-two patent family members in eight countries.

The generic ingredient in TRUDHESA is dihydroergotamine mesylate. Additional details are available on the dihydroergotamine mesylate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top